IVBT (Innovation1 Biotech) ROC %: -1,132.08% (As of Feb. 2024)

What is Innovation1 Biotech ROC %?

Innovation1 Biotech IVBT 12 ROC % is -1,132.08% as of Feb. 2024. GuruFocus rates IVBT with a GF Score™ of 12/100.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Innovation1 Biotech's annualized return on capital (ROC %) for the quarter that ended in Feb. 2024 was -1,132.08%.

As of today (2026-06-25), Innovation1 Biotech's WACC % is 0.00%. Innovation1 Biotech's ROC % is 0.00% (calculated using TTM income statement data). Innovation1 Biotech earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Innovation1 Biotech (OTCPK:IVBT) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Innovation1 Biotech's WACC % is 0.00%. Innovation1 Biotech's ROC % is 0.00% (calculated using TTM income statement data). Innovation1 Biotech earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Innovation1 Biotech ROC % Related Terms

Innovation1 Biotech ROC % Historical Data

* Premium members only.

The historical data trend for Innovation1 Biotech's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation1 Biotech ROC % Chart

Innovation1 Biotech Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

ROC %

Get a 7-Day Free Trial

-173.68

-17.85

-19.30

-14.47

-3.50

Innovation1 Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
ROC %	Get a 7-Day Free Trial															-25.47	-22.03	-38.53	-1,890.91	-1,132.08

12GF Score

Innovation1 Biotech Inc IVBT

ROC % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Innovation1 Biotech ROC % Calculation

Innovation1 Biotech's annualized Return on Capital (ROC %) for the fiscal year that ended in Aug. 2023 is calculated as:

	ROC % (A: Aug. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Aug. 2022 )	+	Invested Capital (A: Aug. 2023 ))	/ count )
=	-1.267 * ( 1 - 0% )	/	( (72.385	+	0.013)	/ 2 )
=	-1.267	/	36.199
=	-3.50 %

where

	Invested Capital		(A: Aug. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	43.963	-	1.103	-	( 0.156	-	max(0, 29.812	-	0.287	+	0.156	))
=	72.385

	Invested Capital		(A: Aug. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.076	-	3.277	-	( 0.05	-	max(0, 3.287	-	0.073	+	0.05	))
=	0.013

Innovation1 Biotech's annualized Return on Capital (ROC %) for the quarter that ended in Feb. 2024 is calculated as:

	ROC % (Q: Feb. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Nov. 2023 )	+	Invested Capital (Q: Feb. 2024 ))	/ count )
=	-0.6 * ( 1 - 0% )	/	( (0.053	+	0.053)	/ 2 )
=	-0.6	/	0.053
=	-1,132.08 %

where

	Invested Capital		(Q: Nov. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.02	-	2.606	-	( 0.006	-	max(0, 2.656	-	0.017	+	0.006	))
=	0.053

	Invested Capital		(Q: Feb. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.122	-	2.854	-	( 0.108	-	max(0, 2.904	-	0.119	+	0.108	))
=	0.053

Note: The Operating Income data used here is four times the quarterly (Feb. 2024) data. The tax rate is limited to between 0% and 100%.

Frequently Asked Questions Learn more about ROC % →

What does a ROC % of -1,132.08% mean?

Innovation1 Biotech (IVBT) has a ROC % of -1,132.08% as of Feb. 2024. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Innovation1 Biotech and its competitors.

Is Innovation1 Biotech's ROC % too high?

Innovation1 Biotech's current ROC % is -1,132.08%. Overall, Innovation1 Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Innovation1 Biotech's ROC % compare to NVIV and PXMD?

Innovation1 Biotech's ROC % of -1,132.08% can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROC % for a Diversified Financial Services company?

A good ROC % depends on the Diversified Financial Services industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROC % mean?

A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Innovation1 Biotech and its competitors. Innovation1 Biotech's current ROC % is -1,132.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Innovation1 Biotech stock overvalued right now?

Innovation1 Biotech (IVBT) has a current ROC % of -1,132.08%. The current ROC % is -1,132.08%. Innovation1 Biotech's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROC % calculated?

ROC % is calculated from a company's financial statements. For Innovation1 Biotech (IVBT), the current ROC % is -1,132.08% as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation1 Biotech Business Description

Industry Financial Services Diversified Financial Services

Comparable Companies NVIV PXMD SCNI PHIO SLRX GBLX SNPX RVLPQ THAR ATXI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Address 7 Grand View Avenue, Somerville, MA, USA, 02143

Website https://www.innovation1bio.com

Innovation1 Biotech Inc is a shell company.

12GF Score

Get the complete analysis for IVBT

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View IVBT Analysis

See ROC % data for all stocks →